Validation of the International Working Group Proposal for SF3B1 Mutant Myelodysplastic Syndromes.
Sign Up to like & getrecommendations! Published in 2021 at "Blood"
DOI: 10.1182/blood.2021010831
Abstract: Komrokji et al examined the proposed international working group proposal to designate SF3B1-mutant myelodysplastic syndrome (MDS) as a unique disease entity, using a single-institution validation cohort of 1779 MDS patients, of whom 320 harbored SF3B1… read more here.
Keywords: mutant myelodysplastic; working group; international working; sf3b1 mutant ... See more keywords